Premier Path Wealth Partners LLC Sells 90 Shares of Zoetis Inc. (NYSE:ZTS)

Premier Path Wealth Partners LLC cut its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 1.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,388 shares of the company’s stock after selling 90 shares during the period. Premier Path Wealth Partners LLC’s holdings in Zoetis were worth $878,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Mercer Global Advisors Inc. ADV raised its position in shares of Zoetis by 12.3% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 49,298 shares of the company’s stock valued at $8,530,000 after acquiring an additional 5,384 shares during the last quarter. GM Advisory Group LLC bought a new stake in Zoetis in the second quarter valued at about $243,000. Canada Pension Plan Investment Board lifted its stake in Zoetis by 7.7% in the second quarter. Canada Pension Plan Investment Board now owns 688,738 shares of the company’s stock valued at $119,400,000 after buying an additional 49,386 shares during the period. Callan Capital LLC boosted its holdings in Zoetis by 7.1% during the second quarter. Callan Capital LLC now owns 2,688 shares of the company’s stock worth $466,000 after buying an additional 178 shares during the last quarter. Finally, AE Wealth Management LLC grew its position in shares of Zoetis by 9.5% during the 2nd quarter. AE Wealth Management LLC now owns 1,988 shares of the company’s stock worth $345,000 after buying an additional 172 shares during the period. Institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

ZTS has been the topic of a number of analyst reports. UBS Group started coverage on shares of Zoetis in a research report on Monday, December 9th. They issued a “neutral” rating and a $196.00 price target on the stock. JPMorgan Chase & Co. increased their target price on shares of Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Leerink Partners initiated coverage on shares of Zoetis in a report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price target for the company. Stifel Nicolaus lowered their price objective on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. Finally, Leerink Partnrs upgraded Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. One investment analyst has rated the stock with a hold rating, nine have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, Zoetis currently has an average rating of “Buy” and a consensus target price of $211.89.

Zoetis Stock Performance

ZTS opened at $166.01 on Friday. The company has a market capitalization of $74.90 billion, a price-to-earnings ratio of 31.20, a P/E/G ratio of 2.51 and a beta of 0.89. The business’s 50-day moving average price is $170.93 and its two-hundred day moving average price is $179.95. Zoetis Inc. has a 1 year low of $144.80 and a 1 year high of $200.53. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27.

Zoetis (NYSE:ZTS) last announced its earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The business had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.29 billion. During the same quarter last year, the firm earned $1.36 EPS. Zoetis’s revenue for the quarter was up 11.6% compared to the same quarter last year. Equities analysts expect that Zoetis Inc. will post 5.91 EPS for the current fiscal year.

Zoetis Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 4th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This is a boost from Zoetis’s previous quarterly dividend of $0.43. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 1.20%. Zoetis’s dividend payout ratio is presently 32.52%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.